Novo Nordisk Pharma AG - NovoNorm 2,0 mg, Tabletten | | 54571 | | 03 | | NovoNorm 2,0 mg | | Tabletten | | A10BX02 | | Repaglinid | | 28.09.1999 | | |
| Composition | repaglinidum 2 mg, poloxamerum 188, povidonum K 25, megluminum, maydis amylum, calcii hydrogenophosphas, cellulosum microcristallinum, glycerolum (85 per centum), polacrilinum kalicum, magnesii stearas, E 172 (rubrum) pro compresso. | Packungsbestandteile | | Comprimés | | | Principe actif | Concentr. |
---|
Repaglinide | 2 mg |
| BAG: Principe actif | Concentr. |
---|
Repaglinide | 2 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
(Rubrum) pro Compresso | | | Calcium Hydrogenophosphate | | | Cellulosum Microcristallinum | | | E 172 | | color. | Glycerol | | | Magnesii Stearas | | | Maydis Amylum | | | Meglumine | | | Polacrilinum Kalicum | | | Poloxamer | 188 | | Povidonum K | 25 | |
| |
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
---|
046 | 90 Comprimé(s) | 13.22 | 30.70 | B | LS | Oui |
|
|